chitosan has been researched along with Leukemia P388 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichikawa, H; Machida, Y; Nagai, T; Onishi, H; Takahata, T | 1 |
Machida, Y; Nagai, T; Onishi, H; Sato, M; Takahara, J | 1 |
2 other study(ies) available for chitosan and Leukemia P388
Article | Year |
---|---|
Evaluation of the conjugate between N4-(4-carboxybutyryl)-1-beta-D-arabinofuranosylcytosine and chitosan as a macromolecular prodrug of 1-beta-D-arabinofuranosylcytosine.
Topics: Animals; Antineoplastic Agents; Body Weight; Chitin; Chitosan; Cytarabine; Drug Carriers; Hydrogen-Ion Concentration; Leukemia P388; Longevity; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred Strains; Prodrugs; Spectrophotometry, Ultraviolet | 1993 |
In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
Topics: Animals; Antibiotics, Antineoplastic; Biopolymers; Body Weight; Chemical Phenomena; Chemistry, Physical; Chitin; Chitosan; Chromatography, Gel; Delayed-Action Preparations; Glycols; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Male; Mice; Mice, Inbred Strains; Mitomycin; Mitomycins; Rats; Rats, Wistar; Sarcoma 180; Succinates; Tumor Cells, Cultured | 1996 |